Cryptocurrency-exposed stocks are declining as Bitcoin drops 3.5% to $84,163. The broader market is also retreating as investors worry about escalating trade tensions following President Trump's latest tariff announcements. TeraWulf leads declines (-8.32%), followed by MARA Holdings (-7.25%), while Coinbase is down 3.89% to $191.75 and Strategy falls 5.3% to $307.
Market Pressures Mount
Bitcoin plunged after Trump's decision to impose a 25% tariff on imported automobiles, adding to earlier tariffs on goods from Mexico, Canada, and China. The total crypto market cap has dropped 2.6% to $2.76 trillion, with Ethereum, XRP, and Dogecoin each declining over 6%. Contributing to volatility is the expiration of $14 billion in Bitcoin and Ethereum options today, which has already triggered $418 million in liquidated positions.
Meanwhile, GameStop's announcement to raise $1.3 billion for Bitcoin purchases has backfired, with its stock plunging 25% and wiping $2.8 billion off its market value. Analysts note cryptocurrencies are "lacking new incoming funds and new narratives" as market participants also eye upcoming U.S. inflation data and potential Federal Reserve responses.
Coinbase, Strategy, Semler Scientific (D1 Interval)
Bitcoin (D1 Interval)
Bitcoin is retesting the 50% Fibonacci retracement level, which was a strong support zone last month. The RSI continues its long-term bearish divergence following an unsuccessful breakout, while the MACD is on the verge of a bearish crossover. Source: xStation
Crypto news: Bitcoin stabilizes after the sell-off 📈December Fed rate cut odds rise
MicroStrategy in trouble? Shares down 67% from the highs ✂
Stock of the Week – NVIDIA (21.11.2025)
DE40: European tech and defence stocks sell-off
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
